Cargando…

Could Antigen Presenting Cells Represent a Protective Element during SARS-CoV-2 Infection in Children?

Antigen Presenting Cells (APC) are immune cells that recognize, process, and present antigens to lymphocytes. APCs are among the earliest immune responders against an antigen. Thus, in patients with COVID-19, a disease caused by the newly reported SARS-CoV-2 virus, the role of APCs becomes increasin...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lauro, Rita, Irrera, Natasha, Eid, Ali H., Bitto, Alessandra
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8071032/ https://www.ncbi.nlm.nih.gov/pubmed/33920011 http://dx.doi.org/10.3390/pathogens10040476

Ejemplares similares

Pros and Cons of the Cannabinoid System in Cancer: Focus on Hematological Malignancies
por: Irrera, Natasha, et al.
Publicado: (2021)

Evidence for using a dual COX 1/2 and 5-LOX inhibitor in neurodegenerative diseases
por: Irrera, Natasha, et al.
Publicado: (2017)

Pharmacogenetics of Biological Agents Used in Inflammatory Bowel Disease: A Systematic Review
por: Lauro, Rita, et al.
Publicado: (2021)

Severe Acute Respiratory Syndrome Coronavirus-2 Induces Cytokine Storm and Inflammation During Coronavirus Disease 19: Perspectives and Possible Therapeutic Approaches
por: Mannino, Federica, et al.
Publicado: (2020)

Polymorphisms Involved in Response to Biological Agents Used in Rheumatoid Arthritis
por: Pallio, Giovanni, et al.
Publicado: (2020)

Role of Adenosine and Purinergic Receptors in Myocardial Infarction: Focus on Different Signal Transduction Pathways
por: Procopio, Maria Cristina, et al.
Publicado: (2021)

Epigenetic Modifications Due to Heavy Metals Exposure in Children Living in Polluted Areas
por: Bitto, Alessandra, et al.
Publicado: (2014)

Flavocoxid, a dual inhibitor of COX-2 and 5-LOX of natural origin, attenuates the inflammatory response and protects mice from sepsis
por: Bitto, Alessandra, et al.
Publicado: (2012)

Retraction Note: Flavocoxid, a dual inhibitor of COX-2 and 5-LOX of natural origin, attenuates the inflammatory response and protects mice from sepsis
por: Bitto, Alessandra, et al.
Publicado: (2023)

Could BCG Vaccination Induce Protective Trained Immunity for SARS-CoV-2?
por: Covián, Camila, et al.
Publicado: (2020)

Polydeoxyribonucleotide: A Promising Biological Platform to Accelerate Impaired Skin Wound Healing
por: Galeano, Mariarosaria, et al.
Publicado: (2021)

Could SARS-CoV-2 cause tauopathy?
por: Pratt, James, et al.
Publicado: (2021)

Fibrosis after Myocardial Infarction: An Overview on Cellular Processes, Molecular Pathways, Clinical Evaluation and Prognostic Value
por: Scalise, Renato Francesco Maria, et al.
Publicado: (2021)

New Approaches and Repurposed Antiviral Drugs for the Treatment of the SARS-CoV-2 Infection
por: Bauso, Luana Vittoria, et al.
Publicado: (2021)

Surface cysteines could protect the SARS-CoV-2 main protease from oxidative damage
por: Ravanfar, Raheleh, et al.
Publicado: (2022)

Could SARS-CoV-2 be associated with emphysematous gastritis?
por: Garrosa-Muñoz, Sonsoles, et al.
Publicado: (2021)

Could the stethoscope be a SARS-CoV-2 vector?
por: Baeza-Trinidad, Ramón, et al.
Publicado: (2022)

Could the stethoscope be a SARS-CoV-2 vector?
por: Baeza-Trinidad, Ramón, et al.
Publicado: (2022)

Could veterinarians be immune to contracting SARS-CoV-2?
por: Kozłowska-Geller, Monika Anna, et al.
Publicado: (2022)

Could Small Neurotoxins-Peptides be Expressed during SARS-CoV-2 Infection?
por: Cafiero, Concetta, et al.
Publicado: (2021)

Pharmacological Activity and Clinical Use of PDRN
por: Squadrito, Francesco, et al.
Publicado: (2017)

Atherosclerosis Plaque Reduction by Lycopene Is Mediated by Increased Energy Expenditure through AMPK and PPARα in ApoE KO Mice Fed with a High Fat Diet
por: Mannino, Federica, et al.
Publicado: (2022)

Corrigendum: Pharmacological activity and clinical use of PDRN
por: Squadrito, Francesco, et al.
Publicado: (2022)

Blunting Neuroinflammation by Targeting the Immunoproteasome with Novel Amide Derivatives
por: Imbesi, Chiara, et al.
Publicado: (2023)

Emerging Evidence and Treatment Perspectives from Randomized Clinical Trials in Systemic Sclerosis: Focus on Interstitial Lung Disease
por: Aragona, Caterina Oriana, et al.
Publicado: (2022)

Beta-Caryophyllene Exhibits Anti-Proliferative Effects through Apoptosis Induction and Cell Cycle Modulation in Multiple Myeloma Cells
por: Mannino, Federica, et al.
Publicado: (2021)

Correction: Mannino et al. Beta-Caryophyllene Exhibits Anti-Proliferative Effects through Apoptosis Induction and Cell Cycle Modulation in Multiple Myeloma Cells. Cancers 2021, 13, 5741
por: Mannino, Federica, et al.
Publicado: (2023)

Living with COVID-19: could SARS-CoV-2 infection present a ping-pong effect?
por: LAGHI, ALESSANDRO, et al.
Publicado: (2021)

Could the Inhibition of Endo-Lysosomal Two-Pore Channels (TPCs) by the Natural Flavonoid Naringenin Represent an Option to Fight SARS-CoV-2 Infection?
por: Filippini, Antonio, et al.
Publicado: (2020)

Beta-Caryophyllene, a Plant-Derived CB2 Receptor Agonist, Protects SH-SY5Y Cells from Cadmium-Induced Toxicity
por: Mannino, Federica, et al.
Publicado: (2023)

Could SARS-CoV-2 be transmitted via speech droplets?
por: Anfinrud, Philip, et al.
Publicado: (2020)

Could the SARS-CoV-2 infection be acquired from Smartphones?
por: Law, Siukan, et al.
Publicado: (2020)

Oral Mucosa Could Be an Infectious Target of SARS-CoV-2
por: Okui, Tatsuo, et al.
Publicado: (2021)

Could the SARS-CoV-2 Infection be Acquired via the Eye?
por: Law, Siukan, et al.
Publicado: (2021)

Could Endogenous Glucocorticoids Influence SARS-CoV-2 Infectivity?
por: Hardy, Eugenio, et al.
Publicado: (2022)

SARS‐CoV‐2 omicron variant: Could it be another threat?
por: Shanmugaraj, Balamurugan, et al.
Publicado: (2022)

HLA variation and antigen presentation in COVID-19 and SARS-CoV-2 infection
por: Augusto, Danillo G, et al.
Publicado: (2022)

Shape Complementarity Optimization of Antibody–Antigen Interfaces: The Application to SARS-CoV-2 Spike Protein
por: De Lauro, Alfredo, et al.
Publicado: (2022)

Enhanced Sampling of the SARS-CoV-2 s2m Element
por: Kensinger, Adam H., et al.
Publicado: (2021)

SARS-CoV-2 Spike-Binding Antibody Longevity and Protection from Reinfection with Antigenically Similar SARS-CoV-2 Variants
por: Kubale, John, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_0m92o6g4v1da5bkfd4uus6605h